Olaris BoR Technology on C-Sessions with Randall Broad

 Olaris CEO and Founder Dr. Liz O'Day had the opportunity to share the origin of BoR technology with C-sessions and describe how our BoRs can be used as a tool to determine which treatment is best for each patient- even before they start therapy. Listen below to learn how Olaris BoRs in oncology can empower patients and providers to be confident in their treatment.

June 3, 2021

Olaris BoR Technology on C-Sessions with Randall Broad